Silence Therapeutics plc (LON:SLN) is engaged in the research and development of pharmaceutical products. In particular the Company is focusing on the development of its ribonucleic acid interference (RNAi) technology, which is moving from the pre-clinical into clinical development phase.
Silence Therapeutics plc
LON:SLN ISIN:GB0008433350
News
Benitec Limited (ASX:BLT) (PINK:BNIKF) are delighted to announce the appointment of Mr Iain Ross to the Board.
###
1,906 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 2) (Last 30 Days: 18) (Since Published: 1906)